AAAAAA
Results:
1-19
|
Results: 19
Authors:
Eisenberg, I
Avidan, N
Potikha, T
Hochner, H
Chen, M
Olender, T
Barash, M
Shemesh, M
Sadeh, M
Grabov-Nardini, G
Shmilevich, I
Friedmann, A
Karpati, G
Bradley, WG
Baumbach, L
Lancet, D
Ben Asher, E
Beckmann, JS
Argov, Z
Mitrani-Rosenbaum, S
Citation: I. Eisenberg et al., The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene ismutated in recessive hereditary inclusion body myopathy, NAT GENET, 29(1), 2001, pp. 83-87
Authors:
Eisenberg, I
Hochner, H
Shemesh, M
Levi, T
Potikha, T
Sadeh, M
Argov, Z
Jackson, CL
Mitrani-Rosenbaum, S
Citation: I. Eisenberg et al., Physical and transcriptional map of the hereditary inclusion body myopathylocus on chromosome 9p12-p13, EUR J HUM G, 9(7), 2001, pp. 501-509
Authors:
Chen, JT
Taivassalo, T
Argov, Z
Arnold, DL
Citation: Jt. Chen et al., Modeling in vivo recovery of intracellular pH in muscle to provide a novelindex of proton handling: Application to the diagnosis of mitochondrial myopathy, MAGN RES M, 46(5), 2001, pp. 870-878
Authors:
Argov, Z
Citation: Z. Argov, Drug-induced myopathies, CURR OP NEU, 13(5), 2000, pp. 541-545
Authors:
Anderson, LVB
Harrison, RM
Pogue, R
Vafiadaki, E
Pollitt, C
Davison, K
Moss, JA
Keers, S
Pyle, A
Shaw, PJ
Mahjneh, I
Argov, Z
Greenberg, CR
Wrogemann, K
Bertorini, T
Goebel, HH
Beckmann, JS
Bashir, R
Bushby, KMD
Citation: Lvb. Anderson et al., Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies), NEUROMUSC D, 10(8), 2000, pp. 553-559
Authors:
Argov, Z
Arnold, DL
Citation: Z. Argov et Dl. Arnold, MR spectroscopy and mr imaging in metabolic myopathies, NEUROL CLIN, 18(1), 2000, pp. 35
Authors:
McNally, EM
Ly, CT
Rosenmann, H
Rosenbaum, SM
Jiang, W
Anderson, LVB
Soffer, D
Argov, Z
Citation: Em. Mcnally et al., Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation, AM J MED G, 91(4), 2000, pp. 305-312
Authors:
Argov, Z
Lofberg, M
Arnold, DL
Citation: Z. Argov et al., Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy, MUSCLE NERV, 23(9), 2000, pp. 1316-1334
Authors:
Boneva, N
Brenner, T
Argov, Z
Citation: N. Boneva et al., Gabapentin may be hazardous in Myasthenia gravis, MUSCLE NERV, 23(8), 2000, pp. 1204-1208
Muscle phosphorus magnetic resonance spectroscopy oxidative indices correlate with physical activity
Authors:
Tartaglia, MC
Chen, JT
Caramanos, Z
Taivassalo, T
Arnold, DL
Argov, Z
Citation: Mc. Tartaglia et al., Muscle phosphorus magnetic resonance spectroscopy oxidative indices correlate with physical activity, MUSCLE NERV, 23(2), 2000, pp. 175-181
Authors:
Argov, Z
Sadeh, M
Mazor, K
Soffer, D
Kahana, E
Eisenberg, I
Mitrani-Rosenbaum, S
Richard, I
Beckmann, J
Keers, S
Bashir, R
Bushby, K
Rosenmann, H
Citation: Z. Argov et al., Muscular dystrophy due to dysferlin deficiency in Libyan Jews - Clinical and genetic features, BRAIN, 123, 2000, pp. 1229-1237
Authors:
Anderson, LVB
Davison, K
Moss, JA
Young, C
Cullen, MJ
Walsh, J
Johnson, MA
Bashir, R
Britton, S
Keers, S
Argov, Z
Mahjneh, I
Fougerousse, F
Beckmann, JS
Bushby, KMD
Citation: Lvb. Anderson et al., Dysferlin is a plasma membrane protein and is expressed early in human development (vol 8, pg 855, 1999), HUM MOL GEN, 8(6), 1999, pp. 1141-1141
Authors:
Anderson, LVB
Davison, K
Moss, JA
Young, C
Cullen, MJ
Walsh, J
Johnson, MA
Bashir, R
Britton, S
Keers, S
Argov, Z
Mahjneh, I
Fougerousse, F
Beckmann, JS
Bushby, KMD
Citation: Lvb. Anderson et al., Dysferlin is a plasma membrane protein and is expressed early in human development, HUM MOL GEN, 8(5), 1999, pp. 855-861
Authors:
Eisenberg, I
Thiel, C
Levi, T
Tiram, E
Argov, Z
Sadeh, M
Jackson, CL
Thierfelder, L
Mitrani-Rosenbaum, S
Citation: I. Eisenberg et al., Fine-structure mapping of the hereditary inclusion body myopathy locus, GENOMICS, 55(1), 1999, pp. 43-48
Authors:
Chen, JT
Argov, Z
Kearney, RE
Arnold, DL
Citation: Jt. Chen et al., Fitting cytosolic ADP recovery after exercise with a step response function, MAGN RES M, 41(5), 1999, pp. 926-932
Authors:
Taivassalo, T
De Stefano, N
Chen, J
Karpati, G
Arnold, DL
Argov, Z
Citation: T. Taivassalo et al., Short-term aerobic training response in chronic myopathies, MUSCLE NERV, 22(9), 1999, pp. 1239-1243
Authors:
Ashkenazi, A
Freeman, S
Argov, Z
Citation: A. Ashkenazi et al., Effects of cholinergic blockers on auditory brain-stem evoked potentials in rats, J NEUR SCI, 164(2), 1999, pp. 124-128
Authors:
Lev, EI
Tur-Kaspa, I
Ashkenazy, I
Reiner, A
Faraggi, D
Shemer, J
Argov, Z
Citation: Ei. Lev et al., Distribution of serum creatine kinase activity in young healthy persons, CLIN CHIM A, 279(1-2), 1999, pp. 107-115
Authors:
Lossos, A
Meiner, Z
Barash, V
Soffer, D
Schlesinger, I
Abramsky, O
Argov, Z
Shpitzen, S
Meiner, V
Citation: A. Lossos et al., Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr(329)Ser mutation in the glycogen-branching enzyme gene, ANN NEUROL, 44(6), 1998, pp. 867-872
Risultati:
1-19
|